Developments in the mechanisms of allergy in 2018 through the eyes of Clinical and Experimental Allergy, Part I.
Journal
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
ISSN: 1365-2222
Titre abrégé: Clin Exp Allergy
Pays: England
ID NLM: 8906443
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
entrez:
14
12
2019
pubmed:
14
12
2019
medline:
20
9
2020
Statut:
ppublish
Résumé
In the first of two linked articles, we describe the development in the mechanisms underlying allergy as described by Clinical & Experimental Allergy and other journals in 2018. Experimental models of allergic disease, basic mechanisms and clinical mechanisms are all covered.
Substances chimiques
Allergens
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1541-1549Informations de copyright
© 2019 John Wiley & Sons Ltd.
Références
Galli SJ, Gordon JR, Wershil BK. Mast cell cytokines in allergy and inflammation. Agents Actions Suppl. 1993;43:209-220.
Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18:693-704.
Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol. 2008;8:478-486.
Chai R, Liu B, Qi F. The significance of the levels of IL-4, IL-31 and TLSP in patients with asthma and/or rhinitis. Immunotherapy. 2017;9:331-337.
Ziegler SF, Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H. The biology of thymic stromal lymphopoietin (TSLP). Adv Pharmacol. 2013;66:129-155.
He R, Geha RS. Thymic stromal lymphopoietin. Ann N Y Acad Sci. 2010;1183:13-24.
Han NR, Oh HA, Nam SY, et al. TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6. J Investig Dermatol. 2014;134:2521-2530.
Nam SY, Kim HY, Han NR, et al. Src-type tyrosine kinase p56lck is critical for thymic stromal lymphopoietin-induced allergic rhinitis. Clin Exp Allergy. 2018;49(11):875-889.
Kim MH, Jeong HJ. Damnacanthal inhibits the NF-kappaB/RIP-2/caspase-1 signal pathway by inhibiting p56lck tyrosine kinase. Immunopharmacol Immunotoxicol. 2014;36:355-363.
Maarouf M, Shi VY. Bleach for atopic dermatitis. Dermatitis. 2018;29:120-126.
Del Rosso JQ, Bhatia N. Status report on topical hypochlorous acid: clinical relevance of specific formulations, potential modes of action, and study outcomes. J Clin Aesthet Dermatol. 2018;11:36-39.
Fukuyama T, Martel BC, Linder KE, Ehling S, Ganchingco JR, Bäumer W. Hypochlorous acid is antipruritic and anti-inflammatory in a mouse model of atopic dermatitis. Clin Exp Allergy. 2018;48:78-88.
Vroman H, Bergen IM, van Hulst JAC, et al. TNF-alpha-induced protein 3 levels in lung dendritic cells instruct TH2 or TH17 cell differentiation in eosinophilic or neutrophilic asthma. J Allergy Clin Immunol. 2018;141:1620-1633.e1612.
Vroman H, Das T, Bergen IM, et al. House dust mite-driven neutrophilic airway inflammation in mice with TNFAIP3-deficient myeloid cells is IL-17-independent. Clin Exp Allergy. 2018;48:1705-1714.
van Helden MJ, Lambrecht BN. Dendritic cells in asthma. Curr Opin Immunol. 2013;25:745-754.
Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol. 2008;8:193-204.
Liu MC, Xiao HQ, Breslin LM, Bochner BS, Schroeder JT. Enhanced antigen presenting and T cell functions during late-phase allergic responses in the lung. Clin Exp Allergy. 2018;48:334-342.
Liu MC, Proud D, Lichtenstein LM, et al. Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol. 2001;108:29-38.
Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62:943-948.
Calderon MA, Casale TB, Nelson HS, Demoly P. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol. 2013;132:1322-1336.
Nelson HS. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective? J Allergy Clin Immunol. 2014;2:144-149; quiz 150-141.
Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol. 2013;131:1361-1366.
Durham SR, Penagos M. Sublingual or subcutaneous immunotherapy for allergic rhinitis? J Allergy Clin Immunol. 2016;137:339-349.e310.
Hesse L, Brouwer U, Petersen AH, et al. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. Clin Exp Allergy. 2018;48:1035-1049.
Mascarell L, Saint-Lu N, Moussu H, et al. Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice. Mucosal Immunol. 2011;4:638-647.
Tourdot S, Airouche S, Berjont N, et al. Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation. Clin Exp Allergy. 2011;41:1784-1792.
Bohle B. Immune mechanisms of SCIT and SLIT: facing possible differences? Clin Exp Allergy. 2014;44:304-306.
Foster PS, Maltby S, Rosenberg HF, et al. Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma. Immunol Rev. 2017;278:20-40.
de Matos OG, Amaral SS, Pereira da Silva PE, et al. Dietary supplementation with omega-3-PUFA-rich fish oil reduces signs of food allergy in ovalbumin-sensitized mice. Clin Dev Immunol. 2012;2012:236564.
Weise C, Hilt K, Milovanovic M, Ernst D, Rühl R, Worm M. Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFkappaB pathway in human B cells. J Nutr Biochem. 2011;22:269-275.
Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20:159-166.
Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341:569-573.
Kunnumakkara AB, Bordoloi D, Padmavathi G, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174:1325-1348.
Abidi A, Gupta S, Agarwal M, Bhalla HL, Saluja M. Evaluation of efficacy of curcumin as an add-on therapy in patients of bronchial asthma. J Clin Diagn Res. 2014;8:Hc19-Hc24.
Chen JW, Kong Z-L, Tsai M-L, et al. Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells. J Food Drug Anal. 2018;26:1075-1085.
Chapoval S, Dasgupta P, Dorsey NJ, Keegan AD. Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J Leukoc Biol. 2010;87:1011-1018.
Chen XH, Patel BK, Wang LM, et al. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules. J Biol Chem. 1997;272:6556-6560.
Chatila TA. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med. 2004;10:493-499.
Berkooz M, Pioline B, Rozali M. Closed strings in Misner space: cosmological production of winding strings. J Cosmol Astropart Phys. 2004;2004. https://doi.org/10.1016/j.molmed.2004.08.004
Amsen D, Antov A, Flavell RA. The different faces of Notch in T-helper-cell differentiation. Nat Rev Immunol. 2009;9:116-124.
O'Byrne PM, Naji N, Gauvreau GM. Severe asthma: future treatments. Clin Exp Allergy. 2012;42:706-711.
O'Byrne PM, Inman MD, Parameswaran K. The trials and tribulations of IL-5, eosinophils, and allergic asthma. J Allergy Clin Immunol. 2001;108:503-508.
Bacon K, Moss E, Bingham K, et al. LATE-BREAKING ABSTRACT: a novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3-muscarinic M3 receptor heterodimers. Eur Respir J. 2015;46:OA288.
Moore WC, Hastie AT, Li X, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2014;133:1557-1563 e1555.
Gibson PG. Inflammatory phenotypes in adult asthma: clinical applications. Clin Respir J. 2009;3:198-206.
Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995;95:843-852.
Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59-99.
Murphy PM. Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol. 1997;34:311-318.
Gao H, Ying S, Dai Y. Pathological roles of neutrophil-mediated inflammation in asthma and its potential for therapy as a target. J Immunol Res. 2017;2017:3743048.
Burgess JK, Boustany S, Moir LM, et al. Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness. Am J Respir Crit Care Med. 2010;181:106-115.
Gaggar A, Weathington N. Bioactive extracellular matrix fragments in lung health and disease. J Clin Invest. 2016;126:3176-3184.
Nissen G, Hollaender H, Tang FSM, et al. Tumstatin fragment selectively inhibits neutrophil infiltration in experimental asthma exacerbation. Clin Exp Allergy. 2018;48:1483-1493.
Monboisse JC, Garnotel R, Bellon G, et al. The alpha 3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes. J Biol Chem. 1994;269:25475-25482.
Shahan TA, Ziaie Z, Pasco S, et al. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Cancer Res. 1999;59:4584-4590.
Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Ann Rev Biochem. 2005;74:385-410.
Monneau Y, Arenzana-Seisdedos F, Lortat-Jacob H. The sweet spot: how GAGs help chemokines guide migrating cells. J Leukoc Biol. 2016;99:935-953.
Rajarathnam K, Sepuru KM, Joseph PRB, Sawant KV, Brown AJ. Glycosaminoglycan interactions fine-tune chemokine-mediated neutrophil trafficking: structural insights and molecular mechanisms. J Histochem Cytochem. 2018;66:229-239.
Proudfoot AE, Handel TM, Johnson Z, et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci USA. 2003;100:1885-1890.
Gschwandtner M, Piccinini AM, Gerlza T, Adage T, Kungl AJ. Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation. Neurosci Lett. 2016;626:164-173.
Gschwandtner M, Strutzmann E, Teixeira MM, et al. Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo. Cytokine. 2017;91:65-73.
Gschwandtner M, Trinker MU, Hecher B, et al. Glycosaminoglycan silencing by engineered CXCL12 variants. FEBS Lett. 2015;589:2819-2824.
Christensen AD, Haase C. Immunological mechanisms of contact hypersensitivity in mice. APMIS. 2012;120:1-27.
Christensen AD, Skov S, Haase C. The role of neutrophils and G-CSF in DNFB-induced contact hypersensitivity in mice. Immun Inflamm Dis. 2014;2:21-34.
Weber FC, Németh T, Csepregi JZ, et al. Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. J Exp Med. 2015;212:15-22.
Vanheule V, Janssens R, Boff D, et al. The positively charged COOH-terminal glycosaminoglycan-binding CXCL9(74-103) peptide inhibits CXCL8-induced neutrophil extravasation and monosodium urate crystal-induced gout in mice. J Biol Chem. 2015;290:21292-21304.
Vanheule V, Crijns H, Poosti F, et al. Anti-inflammatory effects of the GAG-binding CXCL9(74-103) peptide in dinitrofluorobenzene-induced contact hypersensitivity in mice. Clin Exp Allergy. 2018;48:1333-1344.
Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 2019;12:843-850.
Imoto Y, Kato A, Takabayashi T, et al. Short-chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43. Clin Exp Allergy. 2018;48:544-554.
Jacobsen EA, Lee NA, Lee JJ. Re-defining the unique roles for eosinophils in allergic respiratory inflammation. Clin Exp Allergy. 2014;44:1119-1136.
Geslewitz WE, Percopo CM, Rosenberg HF. Eosinophil persistence in vivo and sustained viability ex vivo in response to respiratory challenge with fungal allergens. Clin Exp Allergy. 2018;48:29-38.
Cañas JA, Sastre B, Rodrigo-Muñoz JM, et al. Eosinophil-derived exosomes contribute to asthma remodelling by activating structural lung cells. Clin Exp Allergy. 2018;48:1173-1185.
Percopo CM, Dyer KD, Ochkur SI, et al. Activated mouse eosinophils protect against lethal respiratory virus infection. Blood. 2014;123(5):743-752.
Masuda C, Miyasaka T, Kawakami K, et al. Sex-based differences inCD103+ dendritic cells promote female-predominant Th2 cytokine production during allergic asthma. Clin Exp Allergy. 2018;48:379-393.
Kynyk JA, Mastronarde JG, McCallister JW. Asthma, the sex difference. Curr Opin Pulm Med. 2011;17(1):6-11.
Davidson WF, Leung DY, Beck LA, et al. Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions.". J Allergy Clin Immunol. 2019;143:894-913.
Paller AS, Spergel JM, Mina-Osorio P, Irvine AD. The atopic march and atopic multimorbidity: many trajectories, many pathways. J Allergy Clin Immunol. 2019;143:46-55.
Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441-446.
Chan A, Terry W, Zhang H, et al. Filaggrin mutations increase allergic airway disease in childhood and adolescence through interactions with eczema and aeroallergen sensitization. Clin Exp Allergy. 2018;48:147-155.
Paul AGA, Muehling LM, Eccles JD, Woodfolk JA. T cells in severe childhood asthma. Clin Exp Allergy. 2019;49:564-581.
Shrestha SK, Katelaris C, Dharmage SC, et al. High ambient levels of grass, weed and other pollen are associated with asthma admissions in children and adolescents: a large 5-year case-crossover study. Clin Exp Allergy. 2018;48:1421-1428.
Guibas GV, Tsolia M, Christodoulou I, Stripeli F, Sakkou Z, Papadopoulos NG. Distinction between rhinovirus-induced acute asthma and asthma-augmented influenza infection. Clin Exp Allergy. 2018;48:536-543.
Karayama M, Inui N, Mori K, et al. Respiratory impedance is correlated with airway narrowing in asthma using three-dimensional computed tomography. Clin Exp Allergy. 2018;48:278-287.
Yu Q, Yu X, Zhao W, et al. Inhibition of H3K27me3 demethylases attenuates asthma by reversing the shift in airway smooth muscle phenotype. Clin Exp Allergy. 2018;48:1439-1452.
Tsurikisawa N, Oshikata C, Watanabe M, Tsuburai T, Kaneko T, Saito H. Innate immune response reflects disease activity in eosinophilic granulomatosis with polyangiitis. Clin Exp Allergy. 2018;48:1305-1316.
Hermans MAW, Schrijver B, van Holten-Neelen C, et al. The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release. Clin Exp Allergy. 2018;48:1412-1420.
Roberts G, Almqvist C, Boyle R, et al. Developments in the mechanisms of allergy in 2018 through the eyes of Clinical and Experimental Allergy, Part II. Clin Exp Allergy. 2019;49(12):1606-1621.